Decitabine monohydrate is a nucleoside analogue and potent DNA methyltransferase inhibitor used primarily in the clinical management of myelodysplastic syndromes and certain acute myeloid leukaemias. By… Read more
Decitabine monohydrate is a nucleoside analogue and potent DNA methyltransferase inhibitor used primarily in the clinical management of myelodysplastic syndromes and certain acute myeloid leukaemias. By inhibiting DNA methylation, this therapeutic agent helps reactivate genes essential for cell cycle regulation and apoptosis. To support rigorous pharmaceutical analysis, this category features high-quality reference standards of the Decitabine monohydrate active pharmaceutical ingredient, alongside its related pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These materials are critical for laboratories conducting impurity profiling, method validation, and routine quality control. Utilizing these characterized compounds ensures precision in analytical testing, allowing researchers and quality control scientists to accurately identify degradation products and quantify active content, thereby ensuring the safety and efficacy of the therapeutic formulation throughout its lifecycle.